Danoprevir, an HCV NS3/4A protease inhibitor, improves insulin sensitivity in patients with genotype 1 chronic hepatitis C

✍ Scribed by Moucari, R.; Forestier, N.; Larrey, D.; Guyader, D.; Couzigou, P.; Benhamou, Y.; Voitot, H.; Vidaud, M.; Seiwert, S.; Bradford, B.; Zeuzem, S.; Marcellin, P.

• Book ID: 125815466
• Publisher: BMJ Publishing Group
• Year: 2010
• Tongue: English
• Weight: 234 KB
• Volume: 59
• Category: Article
• ISSN: 0017-5749
• DOI: 10.1136/gut.2010.219089